---
category: news
title: "Roche Introduces AI-based Research Use Only Algorithms Developed For Breast Cancer"
excerpt: "Roche (RHHBY) announced the research use only launch of three new automated digital pathology algorithms, uPath Ki-67 (30-9), uPath ER (SP1) and uPath PR (1E2) image analysis for breast cancer. The company noted that manual methods for quantification of the breast cancer markers can be time consuming and have reported significant interobserver variability,"
publishedDateTime: 2021-12-07T05:10:00Z
originalUrl: "https://www.nasdaq.com/articles/roche-introduces-ai-based-research-use-only-algorithms-developed-for-breast-cancer"
webUrl: "https://www.nasdaq.com/articles/roche-introduces-ai-based-research-use-only-algorithms-developed-for-breast-cancer"
ampWebUrl: "https://www.nasdaq.com/articles/roche-introduces-ai-based-research-use-only-algorithms-developed-for-breast-cancer?amp"
cdnAmpWebUrl: "https://www-nasdaq-com.cdn.ampproject.org/c/s/www.nasdaq.com/articles/roche-introduces-ai-based-research-use-only-algorithms-developed-for-breast-cancer?amp"
type: article
quality: 63
heat: 63
published: false

provider:
  name: Nasdaq
  domain: nasdaq.com

topics:
  - AI in Healthcare
  - AI

secured: "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;d0kN+XfAG0XVqtcFooSR4w=="
---

